Table 2 Summary statistics from health-facility based surveillance sites that received a single round of IRSa.

From: The impact of stopping and starting indoor residual spraying on malaria burden in Uganda

MRCb (District)

Time period

Number of months included

Total outpatient visits, n

Suspected malaria cases, n (% of total)

Tested for malaria, n (% of suspected)

RDTc performed (versus microscopy), n (% of tested)

Confirmed malaria cases, n (% of tested)

Confirmed cases adjusted for testing rate, n

Mean monthly confirmed cases adjusted for testing rate, n

Aboke HCIV (Kole)

Baseline

12

18,361

10,247 (55.8)

8161 (79.6)

7663 (93.9)

6069 (74.4)

7740

645

Evaluation

34

54,826

30,973 (56.5)

30,674 (99.0)

29,064 (94.8)

22,097 (72.0)

22,308

656

Aduku HCIV (Kwania)

Baseline

12

25,439

14,912 (58.6)

11,944 (80.1)

4854 (40.6)

6559 (54.9)

8009

667

Evaluation

31

65,379

32,260 (49.3)

31,337 (97.1)

20,385 (65.1)

15,201 (48.5)

15,534

501

Anyeke HCIV (Oyam)

Baseline

12

30,447

15,873 (52.1)

11,324 (71.3)

8628 (76.2)

7947 (70.2)

11,018

918

Evaluation

34

70,149

33,618 (47.9)

32,522 (96.7)

31,208 (96.0)

21,799 (67.0)

22,375

658

Awach HCIV (Gulu)

Baseline

12

27,375

16,788 (61.3)

15,124 (90.1)

14,932 (98.7)

11,293 (74.7)

12,558

1047

Evaluation

30

69,375

36,760 (53.0)

35,189 (95.7)

34,070 (96.8)

21,879 (62.2)

22,851

762

Lalogi HCIV (Omoro)

Baseline

12

39,517

24,235 (61.3)

23,959 (98.9)

23,951 (99.9)

17,000 (71.0)

17,202

1,434

Evaluation

31

72,449

41,846 (57.8)

41,668 (99.6)

40,804 (97.9)

22,986 (55.2)

23,060

744

Patongo HCIII (Agago)

Baseline

12

21,745

13,482 (62.0)

13,244 (98.2)

12,938 (97.7)

10,032 (75.7)

10,142

845

Evaluation

34

54,486

34,482 (63.3)

33,797 (98.0)

32,176 (95.2)

17,231 (51.0)

17,440

513

Atiak HCIV (Amuru)

Baseline

12

33,077

22,250 (67.3)

19,224 (86.4)

19,151 (99.6)

16,450 (85.6)

19,044

1,587

Evaluation

34

60,750

31,650 (52.1)

30,754 (97.2)

30,541 (99.3)

19,766 (64.3)

20,325

598

Padibe HCIV (Lamwo)

Baseline

12

15,967

10,212 (64.0)

10,096 (98.9)

10,089 (99.9)

8171 (80.9)

10,089

841

Evaluation

28

50,117

26,883 (53.6)

26,831 (99.8)

25,956 (96.7)

15,199 (56.6)

15,224

544

Namokora HCIV (Kitgum)

Baseline

12

20,291

16,969 (83.6)

15,991 (94.2)

14,918 (93.3)

10,049 (62.8)

10,722

894

Evaluation

31

56,765

40,185 (70.8)

39,966 (99.5)

38,468 (96.3)

21,958 (54.9)

22,063

712

  1. aIndoor residual spraying.
  2. bMalaria Reference Center.
  3. cRapid diagnostic test.